Genome-wide analysis of antidepressant non-response identifies new genetic factors
Author Information
Author(s): Koch Elise, Jürgenson Tuuli, Einarsson Guðmundur, Mitchell Brittany, Harder Arvid, García-Marín Luis M., Krebs Kristi, Lin Yuhao, Shadrin Alexey, Xiong Ying, Frei Oleksandr, Lu Yi, Hägg Sara, Renteria Miguel, Medland Sarah, Wray Naomi, Martin Nicholas, Hübel Christopher, Breen Gerome, Thorgeirsson Thorgeir, Stefansson Hreinn, Stefansson Kari, Lehto Kelli, Milani Lili, Andreassen Ole, O`Connell Kevin
Primary Institution: University of Oslo
Hypothesis
Genetic variation contributes to antidepressant treatment outcomes.
Conclusion
The study identified two novel genetic loci associated with non-response to antidepressants and suggested potential drugs for further investigation.
Supporting Evidence
- Identified two novel loci associated with antidepressant non-response.
- Showed significant polygenic prediction in independent samples.
- Genetic correlation analyses indicated associations with psychiatric traits.
Takeaway
Scientists looked at a lot of people's DNA to find out why some people don't get better with antidepressants, and they found some new clues that could help in the future.
Methodology
The study combined data from various cohorts and performed genome-wide association meta-analyses to identify genetic loci associated with antidepressant non-response.
Potential Biases
The results may not be directly applicable to non-European populations due to the study's focus on individuals of European ancestry.
Limitations
The study combined samples with different assessment methods for treatment non-response, which may introduce heterogeneity.
Participant Demographics
The participants were primarily of European ancestry.
Statistical Information
P-Value
3.55e-08
Confidence Interval
1.005–1.039
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website